The program, which will make weight loss drugs eligible for people on Medicare for $50 a month, is only set to run for 18 ...

For the first time ever, Medicare will cover drugs like Wegovy and Zepbound. But a strict BMI checklist and a 2027 deadline ...

Orforglipron is the active ingredient in Foundayo, the weight management pill approved in April 2026 by the U.S. Food and ...

A Wisconsin woman says a fake celebrity endorsement on Instagram convinced her to buy a weight-loss product after a video ...

Beginning July 1, millions of Medicare beneficiaries will have access to popular GLP-1 weight-loss medications under a new federal demonstration program that dramatically reduces the cost of the drugs ...

The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers ...

For the first time, Medicare will cover GLP-1 drugs prescribed solely for weight loss for eligible beneficiaries at a $50 ...

Millions of Medicare enrollees will gain their first-ever coverage for drugs for weight loss under a temporary pilot program ...

Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...

Fatty15 reports metabolic health is more important than weight loss, focusing on factors like blood sugar and cholesterol, ...

A Green Bay woman is warning others after she said a fake celebrity endorsement on Instagram convinced her to purchase a product making what she described as “magic cure” claims. Chrissy Magnin told ...

A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...